HCA Healthcare Rg
HCA
USD
STOCK MARKET:
NYX
Closed
 
...
Price in deferred time of 15 minutes
Last quote
03/31/2023 - 16:15:00
Bid
03/31/2023 - 16:00:00
Bid
Volume
Ask
03/31/2023 - 16:00:00
Ask
Volume
263.68
+4.24 ( +1.63% )
263.45
2,000
263.46
4,700
More information
Analysis by TheScreener
31.03.2023
Evaluation Neutral  
Interest Very strong  
Sensibility Middle  
Analysis date: 31.03.2023
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 31.01.2023.
Interest
  Very strong
Very strong interest since 21.03.2023.
Earnings Rev Trend
  0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 20.12.2022 at a price of 238.36.
Evaluation
  Neutral
 
Based on its growth potential and our own criteria, at its current price the stock is fairly valued.
MT Tech Trend
  Positive
 
The forty day Medium Term Technical Trend is positive since 21.03.2023. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 248.407.
4wk Rel Perf
  4.92%
 
The four week relative overperformance versus SP500 is 4.92%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 19.07.2022.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.50%.
Mkt Cap in $bn
  73.11
With a market capitalization >$8bn, HCA HEALTHCARE is considered a large-cap stock.
G/PE Ratio
  0.99
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  11.59
The estimated PE is for the year 2025.
LT Growth
  10.42%
The annualized growth estimate is for the current year to 2025.
Avg. Nb analysts
  18
Over the last seven weeks, an average of 18 analysts provided earnings per share estimates.
Dividend Yield
  1.08%
The twelve month estimated dividend yield represents 12.51% of earnings forecasts.
Beta
  113
For 1% of index variation, the stock varies on average by 1.13%.
Correlation
  0.65
65.12% of stock movements are explained by index variations.
Value at Risk
  62.37
The value at risk is estimated at USD 62.37. The risk is therefore 23.65%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  27.07.2011